Touchstone
Last syncNov 1, 2026, 6:55 PM ET

MMED

Minimed Group, Inc. Health Care Surgical & Medical Instruments & Apparatus Russell 3000
$18.28Close $5.1BMarket cap $10.80 – $23.8452-week range

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Apr 24, 2026 · filed Sep 14, 2026
Off 12-month high 23%
1wk down 0.3% price change
1mo down 6.1% price change
12-month return down 1% total, dividends included
F-score — — Not assessed
Altman Z 3.69 Low risk
P/E — price / earnings
PEG — P/E / EPS growth
P/B 1.4× price / book
Earnings yield down 3.9% EBIT / enterprise value
Cheaper than 36% of the market · expensive
Revenue growth up 14% year on year
EPS growth — latest quarter
Sales growth up 17% latest quarter · +1 pts
ROE down 10% return on equity
Free cash margin down 14% -$420.0M FCF
D/E — long-term debt / equity
Net debt / EBITDA —
Interest cover —EBIT / interest

Trade setup

ATR% 4.8% $0.88 a day · 2×ATR $16.51
RS — vs the universe
Trend — trend template
Relative volume 0.9× vs 50-day average
Up/down volume 0.72 50 sessions
Implied move — no scheduled report

Screen verdict

Did not qualify for any screen.

Warning signs

1 flagged
  • Gross margin narrowing Gross margin fell from 56.3% to 54.2%. The company is keeping less of each dollar of sales than it did a year ago.
Last reported Sep 1, 2026
Results reaction Sep 1, 2026+18% vs market2 sessions after results

Financials

3 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $3.1B +14% on FY2025
$0 $5B FY24 FY25 FY26 FY2024 · $2.5B FY2025 · $2.7B FY2026 · $3.1B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology -$333.0M
-$500M $0 FY24 FY25 FY26 FY2024 · -$112.0M FY2025 · -$213.0M FY2026 · -$333.0M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology -$420.0M
-$500M $0 FY24 FY25 FY26 FY2024 · -$107.0M FY2025 · -$53.0M FY2026 · -$420.0M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 54%
  • Net -11%
  • Free cash -14%
-20% 0% 100% FY24 FY25 FY26 FY2024 · Gross 58% · Net -5% · Free cash -4% FY2025 · Gross 56% · Net -8% · Free cash -2% FY2026 · Gross 54% · Net -11% · Free cash -14%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology
  • Cash
  • Long-term debt
$0 $500M FY24 FY25 FY26 FY2024 · Cash $54.0M FY2025 · Cash $11.0M FY2026 · Cash $298.0M
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 280.82m
280.82m 0 FY24 FY25 FY26 FY2024 · 0 FY2025 · 0 FY2026 · 280.82m
  FY2024Apr 26, 2024 FY2025Apr 25, 2025 FY2026Apr 24, 2026
Revenue $2.5B $2.7B $3.1B
Gross margin 58% 56% 54%
Operating income -$69.0M -$146.0M -$190.0M
Net income -$112.0M -$213.0M -$333.0M
Net margin -5% -8% -11%
Earnings per share -$0.44 -$0.84 -$1.30
Free cash flow -$107.0M -$53.0M -$420.0M
Free cash margin -4% -2% -14%
Cash $54.0M $11.0M $298.0M
Shareholders' equity $3.4B $3.3B $3.6B
Shares outstanding 0 0 280.82m